Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


Breaking News In Prostate Cancer Diagnoses
The PCA3 urine test and a new image-guided prostate biopsy may revolutionize prostate cancer diagnosis and treatment, says robotic prostate surgeon, David Samadi, MD.

NEW YORK, Dec. 14, 2012 /PRNewswire/ -- Despite the volume of prostate cancer tests and treatments, experts and their patients are continually challenged to predict the disease's course and apply the most appropriate treatment. Now, two new diagnostic innovations – the PCA3 urine test and a more targeted prostate biopsy technique - could refine the way doctors diagnose prostate cancer and, subsequently, the way patients elect to treat it.

(Photo: http://photos.prnewswire.com/prnh/20121214/NY29576 )

Current prostate cancer tests yield limited results. The prostate-specific antigen (PSA) blood test indicates the potential presence of prostate cancer, but it cannot predict disease type or aggression. The prostate biopsy confirms a prostate cancer diagnosis, but tissue retrieval is challenged by prostate gland size and placement and can result in missed tumors. Prostate cancer treatment expert, Dr. David Samadi, relies on both exams prior to recommending and performing his Samadi Modified Advanced Robotic Technique (SMART) prostate removal surgery, but agrees that testing could be enhanced. "Prostate cancer innovations like these will continually improve the life-saving benefits of early diagnosis and intervention," said Dr. Samadi.

What is PCA3?
PCA3, prostate cancer gene 3, is a gene-based urine test believed to more accurately predict the presence of prostate cancer and its future course. Unlike PSA level, PCA3 is not affected by other prostate conditions, such as benign prostatic hyperplasia (BPH), so results are more reliable.

"There are two viable applications for PCA3 scoring," explained Dr. Samadi. "If we learn that a man's PCA3 is elevated before biopsy, we can proceed with greater certainty of the biopsy's necessity. After biopsy, the test could help assess the urgency with which we treat the disease. Both applications could give greater peace of mind to men weighing treatment options, particularly robotic prostate removal surgery," he said.

More Targeted Prostate Biopsy
Researchers at the University of California Los Angeles (UCLA) published findings of an image-guided prostate biopsy study in this month's Journal of Urology, http://www.jurology.com/article/S0022-5347(12)04714-3/abstract. Attempting to produce more accurate biopsy results, they combined the imaging capabilities of MRI with ultrasound. Using this new prostate map, the biopsies performed under their study yielded a positive prostate cancer diagnosis in 53 percent of the 171 participants.

"Prostate biopsies can yield uncertain results," explains Dr. Samadi. "But using enhanced, overlaid imaging to more accurately collect prostate tissue is very similar to the robotically-enhanced visibility used during robotic surgery. This new, targeted approach mirrors the refinements afforded by the robot and could yield equally positive results."

David Samadi is Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at New York's Mount Sinai Medical Center where he has performed more than 4,000 successful SMART prostate removals.

Related Links:

http://www.roboticoncology.com
http://www.smart-surgery.com

Related Videos:

SMART Robotic Prostate Surgery - David Samadi, MD
http://www.youtube.com/watch?feature=player_embedded&v=wRNPA5npn6Y

PSA Test: Prostate Screening Saves Lives
http://www.youtube.com/watch?v=HYxPqdPdZIA

PROSTATE CANCER NEWS - Prostate Surgery Takes a Team
http://www.youtube.com/watch?v=XjbYCGxRLz8

 

SOURCE roboticoncology.com

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
SYS-CON Events announced today that ActiveState, the leading independent Cloud Foundry and Docker-based PaaS provider, has been named “Silver Sponsor” of SYS-CON's DevOps Summit New York, which will take place June 9-11, 2015, at the Javits Center in New York City, NY. ActiveState bel...
The 5th International DevOps Summit, co-located with 17th International Cloud Expo – being held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, a...
SYS-CON Events announced today that Intelligent Systems Services will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Established in 1994, Intelligent Systems Services Inc. is located near Washin...
Community is an area of great interest to me. As the evangelist for VictorOps, I’m tapped with many challenges and responsibilities. Not only do I try to provide useful guidance and feedback regarding VictorOps and DevOps best practices, but also bring together customers and partners w...
2015 is the 10th birthday of Ruby on Rails (or simply called Rails), the popular open source web application framework that uses the Ruby programming language. Ever since Rails burst on the scene a decade ago it has continued to scale up as an elegant way to build dynamic websites quic...
The primary objective of a platform should be to provide a high-level of automation. This provides easy management of applications and services, while delivering consistent and error-free deployment of applications. While this high level automation provides a critical foundation, addit...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE